Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2010-12-03

FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved a supplemental application for fluphenazine hydrochloride filed by PAI Holdings (PAI Pharma) to update the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

SUPPL AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)